Medpace Holdings, Inc. (MEDP) Gross Margin
- Gross margin · 12 months: Value (m); Formula and calculation Gross profit / revenue. Period ending 2026-06-30..
Gross margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | (m) | Gross profit / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | (m) | |
| Revenue | 2.78B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-06-30 | (m) | $2.78B | (m) | (m) |
| 2026-03-31 | (m) | $2.68B | (m) | (m) |
| 2025-12-31 | (m) | $2.53B | (m) | (m) |
| 2025-09-30 | (m) | $2.36B | (m) | (m) |
| 2025-06-30 | (m) | $2.23B | (m) | (m) |
| 2025-03-31 | (m) | $2.16B | (m) | (m) |
| 2024-12-31 | (m) | $2.11B | (m) | (m) |
| 2024-09-30 | (m) | $2.07B | (m) | (m) |
| 2024-06-30 | (m) | $2.03B | (m) | (m) |
| 2024-03-31 | (m) | $1.96B | (m) | (m) |
| 2023-12-31 | (m) | $1.89B | (m) | (m) |
| 2023-09-30 | (m) | $1.78B | (m) | (m) |
| 2023-06-30 | (m) | $1.67B | (m) | (m) |
| 2023-03-31 | (m) | $1.56B | (m) | (m) |
| 2022-12-31 | (m) | $1.46B | (m) | (m) |
| 2022-09-30 | (m) | $1.37B | (m) | (m) |
| 2022-06-30 | (m) | $1.29B | (m) | (m) |
| 2022-03-31 | (m) | $1.21B | (m) | (m) |
| 2021-12-31 | (m) | $1.14B | (m) | (m) |
| 2021-09-30 | (m) | $1.09B | (m) | (m) |
| 2021-06-30 | (m) | $1.03B | (m) | (m) |
| 2021-03-31 | (m) | $955.01M | (m) | (m) |
| 2020-12-31 | (m) | $925.92M | (m) | (m) |
| 2020-09-30 | (m) | $896.13M | (m) | (m) |
| 2020-06-30 | (m) | $882.00M | (m) | (m) |
| 2020-03-31 | (m) | $891.11M | (m) | (m) |
| 2019-12-31 | (m) | $860.97M | (m) | (m) |
| 2019-09-30 | (m) | $823.20M | (m) | (m) |
| 2019-06-30 | (m) | $786.21M | (m) | (m) |
| 2019-03-31 | (m) | $742.25M | (m) | (m) |
| 2018-12-31 | (m) | $704.59M | (m) | (m) |
| 2018-09-30 | (m) | $625.16M | (m) | (m) |
| 2018-06-30 | (m) | $556.55M | (m) | (m) |
| 2018-03-31 | (m) | (m) | (m) | (m) |
| 2017-12-31 | (m) | $436.15M | (m) | (m) |
| 2017-09-30 | (m) | $431.71M | (m) | (m) |
| 2017-06-30 | (m) | $428.87M | (m) | (m) |
| 2017-03-31 | (m) | $428.61M | (m) | (m) |
| 2016-12-31 | (m) | $421.58M | (m) | (m) |
| 2016-09-30 | (m) | (m) | (m) | (m) |
| 2016-06-30 | (m) | (m) | (m) | (m) |
| 2016-03-31 | (m) | (m) | (m) | (m) |
| 2015-12-31 | (m) | $359.06M | (m) | (m) |
| 2015-09-30 | (m) | (m) | (m) | (m) |
| 2014-12-31 | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |